Purple Biotech Ltd. Logo

Purple Biotech Ltd.

Develops cancer therapies to overcome tumor immune evasion and drug resistance.

PPBT | TA

Overview

Corporate Details

ISIN(s):
IL0007650166
LEI:
Country:
Israel
Address:
Oppenheimer 4, 7670104 Rehovot

Description

Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-15 15:29
6K:Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR…
English 36.5 KB
2022-11-10 00:46
CORPORATE PRESENTATION-NOVEMBER 2022
English 5.3 MB
2022-11-10 00:46
CORPORATE PRESENTATION-NOVEMBER 2022
English 36.5 KB
2022-11-08 16:05
Biotech Reports Third Quarter 2022 Financial Results
English 176.7 KB
2022-11-08 16:05
Biotech Reports Third Quarter 2022 Financial Results
English 36.6 KB
2022-11-02 14:47
6K:Purple Biotech Appoints Lior Fhima as Chief Financial Officer
English 169.4 KB
2022-11-02 14:47
6K:Purple Biotech Appoints Lior Fhima as Chief Financial Officer
English 36.4 KB
2022-08-28 00:34
results of the Annual General Meeting of Shareholders of the Company held on Au…
English 125.5 KB
2022-08-28 00:34
results of the Annual General Meeting of Shareholders of the Company held on Au…
English 36.6 KB
2022-08-04 16:40
Reports Second Quarter 2022 Financial Results
English 232.8 KB
2022-08-04 16:40
Reports Second Quarter 2022 Financial Results
English 36.5 KB
2022-07-19 01:35
Notice of annual general meeting that will be held on August 25, 2022 , Proxy S…
English 74.3 KB
2022-07-19 01:35
Notice of annual general meeting that will be held on August 25, 2022 , Proxy S…
English 839.5 KB
2022-07-19 01:35
Notice of annual general meeting that will be held on August 25, 2022 , Proxy S…
English 135.2 KB
2022-07-19 01:33
FORM 6-K- Annual General Meeting of Shareholders will be held on August 25, 2022
English 839.5 KB

Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Purple Biotech Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.